Current cardioplegia practice in pediatric cardiac surgery: A North American multiinstitutional survey

Yasuhiro Kotani, James Tweddell, Peter Gruber, Christian Pizarro, Erle H. Austin, Ronald K. Woods, Colleen Gruenwald, Christopher A. Caldarone

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Background There are a wide variety of reported techniques with few comparative trials and no current data available by which surgeons can compare their myopreservation strategies across the specialty. We therefore surveyed congenital heart surgeons to develop a profile of current practice. Methods One hundred twenty-two members of the Congenital Heart Surgeons' Society were surveyed, and 56 responses were analyzed. The survey focused on cardioplegia formulations, dosage and administration, and perfusion strategies for four age groups: neonates, infants, children, and adolescents. All percentages are expressed as percentage of the entire reporting cohort (n = 56). Results Eighty-six percent of surgeons use blood-based cardioplegia versus crystalloid cardioplegia. Microplegia is used in 5%. Blood-based cardioplegia additives include del Nido (38%), customized solutions (32%), St. Thomas, Plegisol, or Baxter (11%), and microplegia (5%). Crystalloid cardioplegia types are Custodiol (7%), St. Thomas, Plegisol, or Baxter (5%), and customized solutions (2%). Cold (

Original languageEnglish
Pages (from-to)923-929
Number of pages7
JournalAnnals of Thoracic Surgery
Volume96
Issue number3
DOIs
Publication statusPublished - Sep 2013
Externally publishedYes

Fingerprint

Induced Heart Arrest
Thoracic Surgery
Pediatrics
Age Groups
Perfusion
Surveys and Questionnaires
Newborn Infant
Surgeons

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery
  • Pulmonary and Respiratory Medicine

Cite this

Current cardioplegia practice in pediatric cardiac surgery : A North American multiinstitutional survey. / Kotani, Yasuhiro; Tweddell, James; Gruber, Peter; Pizarro, Christian; Austin, Erle H.; Woods, Ronald K.; Gruenwald, Colleen; Caldarone, Christopher A.

In: Annals of Thoracic Surgery, Vol. 96, No. 3, 09.2013, p. 923-929.

Research output: Contribution to journalArticle

Kotani, Y, Tweddell, J, Gruber, P, Pizarro, C, Austin, EH, Woods, RK, Gruenwald, C & Caldarone, CA 2013, 'Current cardioplegia practice in pediatric cardiac surgery: A North American multiinstitutional survey', Annals of Thoracic Surgery, vol. 96, no. 3, pp. 923-929. https://doi.org/10.1016/j.athoracsur.2013.05.052
Kotani, Yasuhiro ; Tweddell, James ; Gruber, Peter ; Pizarro, Christian ; Austin, Erle H. ; Woods, Ronald K. ; Gruenwald, Colleen ; Caldarone, Christopher A. / Current cardioplegia practice in pediatric cardiac surgery : A North American multiinstitutional survey. In: Annals of Thoracic Surgery. 2013 ; Vol. 96, No. 3. pp. 923-929.
@article{9fd74c1bc70c4ac78dec0d8d15acf816,
title = "Current cardioplegia practice in pediatric cardiac surgery: A North American multiinstitutional survey",
abstract = "Background There are a wide variety of reported techniques with few comparative trials and no current data available by which surgeons can compare their myopreservation strategies across the specialty. We therefore surveyed congenital heart surgeons to develop a profile of current practice. Methods One hundred twenty-two members of the Congenital Heart Surgeons' Society were surveyed, and 56 responses were analyzed. The survey focused on cardioplegia formulations, dosage and administration, and perfusion strategies for four age groups: neonates, infants, children, and adolescents. All percentages are expressed as percentage of the entire reporting cohort (n = 56). Results Eighty-six percent of surgeons use blood-based cardioplegia versus crystalloid cardioplegia. Microplegia is used in 5{\%}. Blood-based cardioplegia additives include del Nido (38{\%}), customized solutions (32{\%}), St. Thomas, Plegisol, or Baxter (11{\%}), and microplegia (5{\%}). Crystalloid cardioplegia types are Custodiol (7{\%}), St. Thomas, Plegisol, or Baxter (5{\%}), and customized solutions (2{\%}). Cold (",
author = "Yasuhiro Kotani and James Tweddell and Peter Gruber and Christian Pizarro and Austin, {Erle H.} and Woods, {Ronald K.} and Colleen Gruenwald and Caldarone, {Christopher A.}",
year = "2013",
month = "9",
doi = "10.1016/j.athoracsur.2013.05.052",
language = "English",
volume = "96",
pages = "923--929",
journal = "Annals of Thoracic Surgery",
issn = "0003-4975",
publisher = "Elsevier USA",
number = "3",

}

TY - JOUR

T1 - Current cardioplegia practice in pediatric cardiac surgery

T2 - A North American multiinstitutional survey

AU - Kotani, Yasuhiro

AU - Tweddell, James

AU - Gruber, Peter

AU - Pizarro, Christian

AU - Austin, Erle H.

AU - Woods, Ronald K.

AU - Gruenwald, Colleen

AU - Caldarone, Christopher A.

PY - 2013/9

Y1 - 2013/9

N2 - Background There are a wide variety of reported techniques with few comparative trials and no current data available by which surgeons can compare their myopreservation strategies across the specialty. We therefore surveyed congenital heart surgeons to develop a profile of current practice. Methods One hundred twenty-two members of the Congenital Heart Surgeons' Society were surveyed, and 56 responses were analyzed. The survey focused on cardioplegia formulations, dosage and administration, and perfusion strategies for four age groups: neonates, infants, children, and adolescents. All percentages are expressed as percentage of the entire reporting cohort (n = 56). Results Eighty-six percent of surgeons use blood-based cardioplegia versus crystalloid cardioplegia. Microplegia is used in 5%. Blood-based cardioplegia additives include del Nido (38%), customized solutions (32%), St. Thomas, Plegisol, or Baxter (11%), and microplegia (5%). Crystalloid cardioplegia types are Custodiol (7%), St. Thomas, Plegisol, or Baxter (5%), and customized solutions (2%). Cold (

AB - Background There are a wide variety of reported techniques with few comparative trials and no current data available by which surgeons can compare their myopreservation strategies across the specialty. We therefore surveyed congenital heart surgeons to develop a profile of current practice. Methods One hundred twenty-two members of the Congenital Heart Surgeons' Society were surveyed, and 56 responses were analyzed. The survey focused on cardioplegia formulations, dosage and administration, and perfusion strategies for four age groups: neonates, infants, children, and adolescents. All percentages are expressed as percentage of the entire reporting cohort (n = 56). Results Eighty-six percent of surgeons use blood-based cardioplegia versus crystalloid cardioplegia. Microplegia is used in 5%. Blood-based cardioplegia additives include del Nido (38%), customized solutions (32%), St. Thomas, Plegisol, or Baxter (11%), and microplegia (5%). Crystalloid cardioplegia types are Custodiol (7%), St. Thomas, Plegisol, or Baxter (5%), and customized solutions (2%). Cold (

UR - http://www.scopus.com/inward/record.url?scp=84883227816&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84883227816&partnerID=8YFLogxK

U2 - 10.1016/j.athoracsur.2013.05.052

DO - 10.1016/j.athoracsur.2013.05.052

M3 - Article

C2 - 23915588

AN - SCOPUS:84883227816

VL - 96

SP - 923

EP - 929

JO - Annals of Thoracic Surgery

JF - Annals of Thoracic Surgery

SN - 0003-4975

IS - 3

ER -